Epilepsi ve Damgalanma: Bir Gözden Geçirme

ay, rukiye

Epilepsi ve Damgalanma: Bir Gözden Geçirme

Rukiye AY (Dr., Malatya Devlet Hastanesi, Psikiyatri Bölümü, Malatya)

Klinik Psikiyatri Dergisi

9 2

Yıl: 2017 Cilt: 20 Sayı: 2 Sayfa Aralığı: 129 - 136 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Epilepsi ve Damgalanma: Bir Gözden Geçirme

Öz:

Toplum tarafından tehlikeli ve ürkütücü olduğu düşünülen epilepsi, sık görülen nörolojik bir hastalıktır. Kullanılan ilaçlarla epileptik nöbetler yüksek oranda kontrol altına alınsa bile, bu hastalığa yönelik korkutucu ön yargılar halen devam etmektedir. Epilepsiye yönelik damgalanmanın düzeyini etkileyen bir çok faktör vardır. Hasta yaşı, medeni durumu, eğitim durumu, hastalığın başlangıç yaşı, tedavi süresi, ilaç yan etkileri, eşlik eden fiziksel ve psikiyatrik bozukluklar, damgalayanların eğitim düzeyleri, hastalık hakkında bilgi düzeyleri bu faktörler arasında sayılabilir. Damgalanmanın hastanın yaşam kalitesi, tedaviye uyumu, sosyal ve mesleki işlevselliği gibi alanlarda olumsuz sonuçları gözlenmektedir. Bu yazının amacı, epilepsi hastalarının tedavisini zorlaştıran ve yaşam kalitelerini bozan damgalanma hakkında farkındalığı arttırmaktır.

Anahtar Kelime:

Konular: Psikiyatri

Epilepsy and Stigmatization: A review

Öz:

Epilepsy, which is considered dangerous and scary by thesociety, is a frequent neurological disease. Althoughepileptic seizures can be controlled with drugs, prejudices towards this disease being scary still continue.There are several factors that determine the level ofstigmatization directed to epilepsy. Age, marital status,education of the patient, age of disease onset, thetreatment duration of the disease, drug side effects,accompanying physical and psychiatric disorders, education level of those stigmatizing and disease-relatedknowledge level are among these factors. Adverse outcomes are observed in many areas such as quality of life,treatment complience, social and occupational functionality. The aim of this article is to increase the awarenessof stigmatization that hampers the treatment and quality of life of epilepsy patients

Anahtar Kelime:

Konular: Psikiyatri

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık

1. Schulze B, Angermeyer MC. Subjective experiences of stigma. A focus group study of schizophrenic patients, their relatives and mental health professionals. Soc Sci Med 2003; 56(2): 299-312.
2. Yýldýrým Z. Türk toplumunda epilepsi ve stigmanýn deðerlendirilmesi, epilepsi hastalarýnda stigma ve depresyonun iliþ- kisinin araþtýrýlmasý. Bakýrköy ruh saðlýðý ve sinir hastalýklarý eðitim ve araþtýrma hastanesi. Uzmanlýk tezi. 2016.
3. Üçok A. Þizofreni: Stigma, mitler ve gerçekler. Psikiyatri Dünyasý 1999; 3:67-71.
4. Link BG, Phelan JC. On stigma and its public health implications. Paper presented at US NIH conference on stigma and global health: developing a research agenda, Bethesda MD.(2001) http://www.stigmaconference.nih.gov (accessed oct, 2016)
5. Link BG. Understanding labelling effects in the area of mental disorders: an assessment of the effects of expectations of rejection. AM Sociol Rev 1987; 52: 96-112
6. Scambler G, Hopkins A. Generating a model of epileptic stigma: the role ofqualitative analysis. Soc Sci Med 1990; 30: 1187- 1194.
7. Jacoby A, Austin JK. Social stigma for adults and children with epilepsy. Epilepsia 2007; 48(9): 6-9.
8.Aydemir N, Ozkara C, Unsal P, Canbeyli R. A comparative study of health related quality of life, psychological well-being, impact of illness and stigma in epilepsy and migraine. Seizure 2011; 20: 679-685.
9. Baker GA, Jacoby A, Buck D, Brooks J, Potts P, Chadwick DW. The quality of life of older people with epilepsy: findings from a UK community study. Seizure 2001; 10(2): 92-99.
10. Gilliam F, Kuzniecky R, Faught E, Black L, Carpenter G, Schrodt R. Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia 1997; 38(2): 233-236.
11. Fiest KM, Birbeck GL, Jacoby A, Jette N. Stigma in epilepsy. Curr Neurol Neurosci Rep 2014; 14(5): 444.
12. Jacoby A, Snape D, Baker GA. Epilepsy and social identity: the stigma of a chronic neurological disorder. Lancet Neurol 2005; 4(3): 171-178.
13. Herrmann LK, Welter E, Berg AT, Perzynski AT, Van Doren JR, Sajatovic M. Epilepsy misconceptions and stigma reduction: Current status in Western countries. Epilepsy Behav 2016; 60: 165-173.
14. Dawkins JL, Crawford PM, Stammers TG. Epilepsy: a general practice study of knowledge and attitudes among sufferers and non-sufferers. Br J Gen Pract 1993; 43(376): 453-457.
15. Doughty J, Baker GA, Jacoby A, Lavaud V. Cross-cultural differences in levels of knowledge about epilepsy. Epilepsia 2003; 44(1):115-123.
16. Sleeth C, Drake K, Labiner DM, Chong J. Felt and enacted stigma in elderly persons with epilepsy: A qualitative approach. Epilepsy Behav 2016; 55:108-112.
17. Taylor J, Baker GA, Jacoby A. Levels of epilepsy stigma in an incident population and associated factors. Epilepsy Behav 2011; 21(3): 255-60.
18. Ghanean H, Jacobsson L, Nojomy M. Self-perception of stigma in persons with epilepsy in Tehran, Iran. Epilepsy Behav 2013; 28: 163-167.
19. Viteva E. Impact of stigma on the quality of life of patients with refractory epilepsy. Seizure 2013; 22: 64-69.
20. Forsgren L, Ghanean H, Jacobsson L, Richter J. On the experience of stigma by persons with epilepsy in Sweden and Iran-A comparative study. Seizure 2013; 22: 748-751.
21. Bielen I, Friedrich L, Sruk A, Prvan MP, Hajnšek S, Petelin Z, Sušak R, Candrli? M, Jacoby A. Factors associated with perceived stigma of epilepsy in Croatia: A study using the revised Epilepsy Stigma Scale. Seizure 2014; 23: 117-121.
22. Leaffer EB, Hesdorffer DC, Begley C. Psychosocial and sociodemographic associates of felt stigma in epilepsy. Epilepsy Behav 2014; 37:104-109.
23. Bautista RED, Shapovalov D, Shoraka AR. Factors associated with increased felt stigma among individuals with epilepsy. Seizure 2015; 30: 106-112.
24. Lee GH, Lee SA, No SK, Lee SM, Ryu JY, Jo KD, Kwon JH, Kim OJ, Park H, Kwon OY, Kim JH, Kim WJ. Factors contributing to the development of perceived stigma in people with newly diagnosed epilepsy: A one-year longitudinal study. Epilepsy Behav 2016; 54:1-6.
25. Aydemir N, Kaya B, Yýldýz G, Oztura I, Baklan B. Determinants of felt stigma in epilepsy. Epilepsy Behav 2016; 58: 76-80.
26. Yeni K, Tulek Z, Bebek N. Factors associated with perceived stigma among patients with epilepsy in Turkey. Epilepsy Behav 2016; 60:142-148.
27. Viteva E. Relation of Perceived Stigma to Adverse Events of Medications in Patients with Epilepsy. Epilepsy Res Treat 2016; doi:10.1155/2016/5362806
28. Jacoby A. Stigma, epilepsy, and quality of life. Epilepsy Behav 2002; 3: 10-20.
29. Whatley AD, DiIorio CK, Yeager K. Examining the relationships of depressive symptoms, stigma, social support and regimen-specific support on quality of life in adult patients with epilepsy. Health Educ Res 2010; 25: 575-584.
30. Jilek-Aall L, Jilek M, Kaaya J, Mkombachepa L, Hillary K. Psychosocial study of epilepsy in Africa. Social Sci Med 1997; 45: 783-795.
31. Basking R, Gretchen LB. Epilepsy-associated stigma in subSaharan Africa: The social landscape of a disease. Epilepsy Behav 2005; 7: 68-73.
32. Osuntokun BO, Odeku EL. Epilepsy in Nigerians: study of 522 patient. Trop Geogr Med 1970; 22:3-19.
33. AK PD, Atakli D, Yuksel B, Guveli BT, Sari H. Stigmatization and social impacts of epilepsy in Turkey. Epilepsy Behav 2015; 50: 50-54.
34. Sheth SG, Krauss G, Krumholz A, Li G. Mortality in epilepsy: driving fatalities vs. other causes of death in patients with epilepsy. Neurology 2004; 63:1002-1007.
35. Krumholz A. Driving issues in epilepsy: past, present, and future. Epilepsy Curr 2009; 9(2):31-35.
36. Birbeck GL. Seizures in rural Zambia. Epilepsia 2000; 41: 277-281.
37. Collins J. Psychosocial well-being and epilepsy: an empirical study. Epilepsia 1990; 31: 418-426.
38. Westbrook LE, Bauman LJ, Hýnnar S. Applying stigma theory to epilepsy: a test of a conceptual model. J Pediatr Psychol 1992; 17(5): 633-649.
39. Buechter R, Pieper D, Ueffing E, Zschorlich B. Interventions to reduce experiences of stigma and discrimination of people with mental illness and their caregivers. Cochrane Database Syst Rev 2013; DOI: 10.1002/14651858.CD010400
40. Schiavo R, May Leung M, Brown M. Communicating risk and promoting disease mitigation measures in epidemics and emerging disease settings. Pathog Glob Health 2014; 108(2):76- 94.

APA	ay r (2017). Epilepsi ve Damgalanma: Bir Gözden Geçirme. , 129 - 136.
Chicago	ay rukiye Epilepsi ve Damgalanma: Bir Gözden Geçirme. (2017): 129 - 136.
MLA	ay rukiye Epilepsi ve Damgalanma: Bir Gözden Geçirme. , 2017, ss.129 - 136.
AMA	ay r Epilepsi ve Damgalanma: Bir Gözden Geçirme. . 2017; 129 - 136.
Vancouver	ay r Epilepsi ve Damgalanma: Bir Gözden Geçirme. . 2017; 129 - 136.
IEEE	ay r "Epilepsi ve Damgalanma: Bir Gözden Geçirme." , ss.129 - 136, 2017.
ISNAD	ay, rukiye. "Epilepsi ve Damgalanma: Bir Gözden Geçirme". (2017), 129-136.

APA	ay r (2017). Epilepsi ve Damgalanma: Bir Gözden Geçirme. Klinik Psikiyatri Dergisi, 20(2), 129 - 136.
Chicago	ay rukiye Epilepsi ve Damgalanma: Bir Gözden Geçirme. Klinik Psikiyatri Dergisi 20, no.2 (2017): 129 - 136.
MLA	ay rukiye Epilepsi ve Damgalanma: Bir Gözden Geçirme. Klinik Psikiyatri Dergisi, vol.20, no.2, 2017, ss.129 - 136.
AMA	ay r Epilepsi ve Damgalanma: Bir Gözden Geçirme. Klinik Psikiyatri Dergisi. 2017; 20(2): 129 - 136.
Vancouver	ay r Epilepsi ve Damgalanma: Bir Gözden Geçirme. Klinik Psikiyatri Dergisi. 2017; 20(2): 129 - 136.
IEEE	ay r "Epilepsi ve Damgalanma: Bir Gözden Geçirme." Klinik Psikiyatri Dergisi, 20, ss.129 - 136, 2017.
ISNAD	ay, rukiye. "Epilepsi ve Damgalanma: Bir Gözden Geçirme". Klinik Psikiyatri Dergisi 20/2 (2017), 129-136.